patritumab,her3-dxd,ruxolitinib
amgen,novartis,daiichi sankyo,incyte
['mbc', 'her3-dxd', 'bcsm', 'rux,(-crux),(-trux)', 'patritumab', 'breast']
insights from the #asco23 annual meeting
her3-dxd for metastatic breast cancer across subtypes
the antibody drug conjugate patritumab deruxtecan. #mbc #bcsm #bio23 #metastatic #breastcancer #clinicaltrials #cancerresearch #denovombc 